153 related articles for article (PubMed ID: 14697909)
21. A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma.
Parmaksiz S; Yüksel N; Karabas VL; Ozkan B; Demirci G; Caglar Y
Eur J Ophthalmol; 2006; 16(1):73-80. PubMed ID: 16496249
[TBL] [Abstract][Full Text] [Related]
22. Prescription of topical antiglaucoma agents for patients with contraindications to beta-blockers.
Houde M; Castilloux AM; Tingey D; Assalian A; LeLorier J
Can J Ophthalmol; 2003 Oct; 38(6):469-75. PubMed ID: 14620034
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.
Shin DH; Feldman RM; Sheu WP;
Ophthalmology; 2004 Feb; 111(2):276-82. PubMed ID: 15019375
[TBL] [Abstract][Full Text] [Related]
24. Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study.
Katz LJ; Rauchman SH; Cottingham AJ; Simmons ST; Williams JM; Schiffman RM; Hollander DA
Curr Med Res Opin; 2012 May; 28(5):781-8. PubMed ID: 22458918
[TBL] [Abstract][Full Text] [Related]
25. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
Netland PA; Landry T; Sullivan EK; Andrew R; Silver L; Weiner A; Mallick S; Dickerson J; Bergamini MV; Robertson SM; Davis AA;
Am J Ophthalmol; 2001 Oct; 132(4):472-84. PubMed ID: 11589866
[TBL] [Abstract][Full Text] [Related]
26. Two-year follow-up of latanoprost 0.005% monotherapy after changing from previous glaucoma therapies.
Bayer A; Weiler W; Oeverhaus U; Skrotzki FE; Stewart WC;
J Ocul Pharmacol Ther; 2004 Dec; 20(6):470-8. PubMed ID: 15684807
[TBL] [Abstract][Full Text] [Related]
27. Costs and effectiveness of travoprost versus a dorzolamide + timolol fixed combination in first-line treatment of glaucoma: analysis conducted on the United Kingdom General Practitioner Research Database.
Lafuma A; Berdeaux G
Curr Med Res Opin; 2007 Dec; 23(12):3009-16. PubMed ID: 17958945
[TBL] [Abstract][Full Text] [Related]
28. Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes.
Gagliuso DJ; Wang RF; Mittag TW; Podos SM
Arch Ophthalmol; 2004 Sep; 122(9):1342-7. PubMed ID: 15364714
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
Lesk MR; Koulis T; Sampalis F; Sampalis JS; Bastien NR
Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402
[TBL] [Abstract][Full Text] [Related]
30. A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients.
Manni G; Centofanti M; Parravano M; Oddone F; Bucci MG
Graefes Arch Clin Exp Ophthalmol; 2004 Sep; 242(9):767-70. PubMed ID: 15241611
[TBL] [Abstract][Full Text] [Related]
31. Ocular hypotensive effects of anti-glaucoma agents in mice.
Akaishi T; Odani-Kawabata N; Ishida N; Nakamura M
J Ocul Pharmacol Ther; 2009 Oct; 25(5):401-8. PubMed ID: 19857101
[TBL] [Abstract][Full Text] [Related]
32. The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
Orzalesi N; Rossetti L; Bottoli A; Fumagalli E; Fogagnolo P
Arch Ophthalmol; 2003 Apr; 121(4):453-7. PubMed ID: 12695241
[TBL] [Abstract][Full Text] [Related]
33. Switching from latanoprost to fixed-combination latanoprost-timolol: a 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension.
Olander K; Zimmerman TJ; Downes N; Schoenfelder J;
Clin Ther; 2004 Oct; 26(10):1619-29. PubMed ID: 15598478
[TBL] [Abstract][Full Text] [Related]
34. Persistency and treatment failure in newly diagnosed open angle glaucoma patients in the United Kingdom.
Zhou Z; Althin R; Sforzolini BS; Dhawan R
Br J Ophthalmol; 2004 Nov; 88(11):1391-4. PubMed ID: 15489479
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the ocular hypotensive effects of bimatoprost and timolol-dorzolamide combination in patients with elevated intraocular pressure: a 6-month study.
Ozturk F; Ermis SS; Inan UU
Acta Ophthalmol Scand; 2007 Feb; 85(1):80-3. PubMed ID: 17244215
[TBL] [Abstract][Full Text] [Related]
36. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.
Parrish RK; Palmberg P; Sheu WP;
Am J Ophthalmol; 2003 May; 135(5):688-703. PubMed ID: 12719078
[TBL] [Abstract][Full Text] [Related]
37. 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.
Walters TR; DuBiner HB; Carpenter SP; Khan B; VanDenburgh AM;
Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S26-35. PubMed ID: 15016559
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension--a three-month randomised study. Spanish Latanoprost Study Group.
García Sanchez J
Eur J Ophthalmol; 2000; 10(3):198-204. PubMed ID: 11071026
[TBL] [Abstract][Full Text] [Related]
39. Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.
Lin L; Zhao YJ; Chew PT; Sng CC; Wong HT; Yip LW; Wu TS; Bautista D; Teng M; Khoo AL; Lim BP
Ann Pharmacother; 2014 Dec; 48(12):1585-93. PubMed ID: 25184309
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of single glaucoma drug in combined timolol XE, latanoprost and brinzolamide therapy: a discontinuation study.
Kobayashi H
J Ocul Pharmacol Ther; 2012 Jun; 28(3):245-50. PubMed ID: 22283238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]